Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.
» More
|
|
|
 |
Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter Catasys Launches OnTrak™ Facebook Page Catasys Health - Monday, January 04, 2010
Check out our new Catasys Health Facebook Recovery Network
http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.
Cutting Edge Treatment for Substance Dependence for Health Plans Catasys Health - Wednesday, December 16, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.
The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak: » More
Changing the Paradigm of Substance Dependent Treatment Catasys Health - Wednesday, December 02, 2009
How OnTrak is Different - We function as a provider in your network and your MBHO’s network, complementing your existing delivery system. We go much deeper than your current programs to address the uniquely difficult needs of your high-utilizing substance dependent members. » More Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence Catasys Health - Wednesday, November 25, 2009
Harold Urschel, Research Across America, Dallas, Texas Raymond Anton, Medical University of South Carolina, Charleston, SC Catasys Health - Saturday, August 01, 2009
Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence Catasys Launches OnTrak Member Website Catasys Health - Tuesday, September 02, 2008
Welcome to OnTrak, a unique treatment program for substance dependence that is covered under your health benefits. We guide you step by step through the transition from substance dependence to sobriety: a process known as recovery. » More
| 1 |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||
 |
|
||||||||||||||||||